[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

O'riordan et al., 2006 - Google Patents

Technology Insight: renal proteomics—at the crossroads between promise and problems

O'riordan et al., 2006

Document ID
10125859472166700738
Author
O'riordan E
Gross S
Goligorsky M
Publication year
Publication venue
Nature Clinical Practice Nephrology

External Links

Snippet

Abstract Knowledge of the human genome has fertilized research in the embryonic field of proteomics. The aim of this Review is to examine the recent application of emerging proteomic technologies to diagnosis of renal disease. We discuss the roles, efficacy and …
Continue reading at www.nature.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/72—Mass spectrometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40—Concentrating samples
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases

Similar Documents

Publication Publication Date Title
Brown et al. Top-down proteomics: challenges, innovations, and applications in basic and clinical research
Cho et al. Oncoproteomics: current trends and future perspectives
Naaby-Hansen et al. Proteomics–post-genomic cartography to understand gene function
Kemna et al. Mass spectrometry–based hepcidin measurements in serum and urine: analytical aspects and clinical implications
Poon Opportunities and limitations of SELDI-TOF-MS in biomedical research: practical advices
Fliser et al. Advances in urinary proteome analysis and biomarker discovery
Steen et al. The ABC's (and XYZ's) of peptide sequencing
Haqqani et al. Quantitative protein profiling by mass spectrometry using label-free proteomics
Fournier et al. Multidimensional separations-based shotgun proteomics
Tuli et al. LC–MS based detection of differential protein expression
Dihazi et al. Characterization of diabetic nephropathy by urinary proteomic analysis: identification of a processed ubiquitin form as a differentially excreted protein in diabetic nephropathy patients
Gutstein et al. Microproteomics: analysis of protein diversity in small samples
Beasley-Green Urine proteomics in the era of mass spectrometry
Thongboonkerd Proteomic analysis of renal diseases: unraveling the pathophysiology and biomarker discovery
JP2004347604A (en) System for analyzing compound mixture of biological fluid, and other fluid for identifying information on biological condition
Gulcicek et al. Proteomics and the analysis of proteomic data: an overview of current protein‐profiling technologies
O'riordan et al. Technology Insight: renal proteomics—at the crossroads between promise and problems
Kruse et al. Chemical and pathway proteomics: powerful tools for oncology drug discovery and personalized health care
Weissinger et al. Online coupling of capillary electrophoresis with mass spectrometry for the identification of biomarkers for clinical diagnosis
O'Riordan et al. Emerging studies of the urinary proteome: the end of the beginning?
Kuruma et al. Proteome analysis of prostate cancer
Haqqani et al. Quantitative protein profiling by mass spectrometry using isotope-coded affinity tags
Smith et al. Application of proteomic analysis to the study of renal diseases
Issaq et al. Electrophoresis and liquid chromatography/tandem mass spectrometry in disease biomarker discovery
Cheng et al. Peptide labeling using isobaric tagging reagents for quantitative phosphoproteomics